DMA110: Demystifying Market Access in the South African Healthcare Environment

Moderated by Mark Brand

Course Summary

Medical device registration e.g. FDA and CE, which are critical quality, safety and efficacy indicators, are merely authorizations to sell a technology, and the absolute minimum requirement for market access, but are not a guarantee for adoption and/or reimbursement; policy makers demand more!

Introducing new technologies to the South Africa Healthcare market is a daunting task, given the potential roadblocks presented by payers and policy makers to manage utilization and health care costs. Although it has a market access focus, this workshop is not exclusively for market access personnel, and every level of business decision-maker will benefit by attending.

Why should you attend?

  • If product and procedure reimbursement is a key factor for successful market access.
  • understand processes that could reduce time bringing products to market.
  • If you are looking at a strategic approach to market access to optimise efficiencies.
  • If you need to successfully communicate a value proposition for your technology.
  • If you want to be part of the solution, not the problem, of managing the business of health care cost effectively.

Who should attend?

Any medical device company representative who is involved in introducing new health technologies to the market, including:

  • Chief Executives,
  • Business Unit Managers,
  • Product Managers,
  • Marketing Managers and
  • Market Access Managers.

Programme

  • HTA102 Guest Lecture - 20 Aug

    Introduction to Health Technology Assessment; an approach to Devices and Technology

  • Study Unit 1: Navigating the South African Healthcare Environment

    • Structure and relationship of stakeholders within the industry (public and private)
    • Unpack the role and responsibilities of stakeholders in the funding industry
    • Navigating market access processes

  • Study Unit 2: Health Technology Management

    • Upstream (pre-launch) activities important for successful market access
    • Principles of health technology assessment (HTA)
    • Downstream (post-launch) activities for sustainable market access

  • Study Unit 3: Developing a Market Access Strategy

    • The value proposition
    • Stakeholder analyses
    • Aligning business and market access strategies
    • Developing the dossier etc

  • 12 weeks self-study

    Duration

  • 30 Points

    CPD accreditation

  • 30 - 40 hours

    Study time

  • Fees (excl VAT)

    R3740 Corp Members
    R3975 Stand Members
    R4210 Ind Members
    R4675 Non Members

  • 3 sessions

    Webinars hosted (excluding HTA102 guest lecture)

Meet the Contributor

Mark Brand

Mark Brand

Guest lecturer for this course - Independent HTA Consultant; MBA; Electrical Engineering; HTA (USB)

Click on image for bio

Scheduled Events

Please note that dates are subject to change. During the lockdown, meetings will be conducted virtually via Zoom.

Jul
17
Fri
8:30 am VIRTUAL CPD – 17 July 2020 @ Zoom - link available in invitation
VIRTUAL CPD – 17 July 2020 @ Zoom - link available in invitation
Jul 17 @ 8:30 am – 10:15 am
VIRTUAL CPD - 17 July 2020 @ Zoom - link available in invitation | Sandton | Gauteng | South Africa
08h45: Login and sound check 09h00: Patient Centric Approach in the management of Type 2 Diabetes Presented by: Dr Julien Trokis 10h15: Wrap up TAKE NOTE: Only those who log in for at least 70% of…
Jul
21
Tue
8:30 am Extra-Ordinary VIRTUAL CPD – 21 ... @ Zoom - link available in invitation
Extra-Ordinary VIRTUAL CPD – 21 ... @ Zoom - link available in invitation
Jul 21 @ 8:30 am – 10:15 am
Extra-Ordinary VIRTUAL CPD - 21 July 2020 @ Zoom - link available in invitation | Sandton | Gauteng | South Africa
This Extra-Ordinary Virtual CPD is open to Funders, PTCMA and SAMA members ONLY 08h45: Login and sound check 09h00: A Metastatic Colorectal Cancer (mCRC) expert session Presented by: Prof Eric van Cutsem (Leuven, Belgium) 10h15: Wrap…
6:45 pm Evening VIRTUAL CPD – 21 July 2020 @ Zoom - link available in invitation
Evening VIRTUAL CPD – 21 July 2020 @ Zoom - link available in invitation
Jul 21 @ 6:45 pm – 8:15 pm
Evening VIRTUAL CPD - 21 July 2020 @ Zoom - link available in invitation | Sandton | Gauteng | South Africa
This Virtual CPD is open to PTCMA and SAMA members ONLY 18h45: Login and sound check 19h00: Current Management of Hypercholesterolaemia and the Role of PCSK9 Inhibitor Therapy Presented by: Prof Derick Raal 20h15: Wrap up…

Latest Newsletter

Find us on